Luján IJE, García RF, Figueroa PG, Hernández MI, Ayala AR

Language: Spanish
References: 13
Page: 568-572
PDF size: 291.00 Kb.

ABSTRACT

Background: Most of the information in medical literature report diverse factors of breast cancer, which are related to the reproductive life of the woman. It is mentioned that menarche before the 12 years elevates the relative risk of this disease, in comparison with its appearance after the 13 years.
Objective: To determine if early menarche is a risk factor associated to breast cancer.
Material and methods: This retrospective, observational and descriptive study included 162 women with breast cancer from a 3 years period (2002-2004), in the Juarez Hospital of Mexico. In addition other well known risk factors for breast cancer were evaluated. The statistical analysis was made with the software program SPSS; the descriptive analysis was made by means of summary of statistics, histograms, box and bar charts.
Results: Early menarche doesn’t have correlation with breast cancer nor with the appearance of the disease in early ages; it was present in the 12.3% (n=20) of the patients; the menarche initiated between 12 and 13 years in 64.4% (n=104.3) of the cases. The average age at the time of the diagnosis of breast cancer in the early menarche group was of 55 years and for the group in general of 47.6 years. The factor that seems to be related to breast cancer is overweight and obesity with 54.26 and 17.11% respectively, with an average body mass index of 27.7 kg/m².
Conclusions: There was not a correlation between early menarche as risk factor for breast cancer neither between the reproductive risk factors considered habitual and increased risk of breast cancer. Overweight and obesity seem to be related to the appearance of the disease, reason why it is required to investigate this with different random control groups in the country. We propose to study other factors that may be implicated in the genesis of breast cancer such as inflammatory factors, similar insulin growth factors and hyperinsulinism.

REFERENCES

1. Ries LAG, Eisner MP, Russo IH, Russo J, et al. SEER Cancer Statistics Review, 1973-1997, National Cancer Institute. NIH Pub. 2000 No. 00-2789. Bethesda, MD.

2. Pharoah DP, Day NE, Land CE, Duffy S. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800-9.

3. Vogel VG. Breast cancer risk factors and preventive approaches to breast cancer. In: Kavanagh JJ, Singletary SE, Einhorn N, et al. editors. Cancer in women. Malden, MA: Blackwell Science, 1998;pp:58-91.

4. Prout MN. Breast cancer risk reduction: what do we know and where should we go? Medscape Women’s Health Journal 2000;5:1-9.

5. Brinton LA, Schaiere C, Hoover RN, Fraumeni JF, et al. Menstrual factors and risk of breast cancer. Cancer Invest 1988;6:145-54.

6. Martínez G, Cano P, González S, Rosales F. Factores predisponentes al cáncer de mama en la Región Lagunera. Ginec Obstet Méx 2004;72:525-30.

7. Paredes A. Factores de riesgo en cáncer de mamario. Gynecol Obstet Méx 1991;59:49-55.

8. Steinberg KK, Thacker SB, Smith SJ, Colditz GA, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-90.

9. White E, Hardy R, Ware JH, Bean J, Leeper J. Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Public Health 1987;77:495-7.

10. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.

11. Harvey EB, Schairer C, Egan KM, Rosner BA, et al. Alcohol consumption and breast cancer. J Natl Cancer Inst 1987;78:657-61.

12. Claus EB, Risch N, Pike MC, Krailo MD, et al. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643-51.

13. Suga K, Imai K, Fukami A, Sakamoto G, et al. Molecular significance of excess body weight in postmenopausal breast cancer patients in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Jpn J Cancer Res 2001;92:127-34.